Review
Published on 15 Aug 2025
CD70 as a target in cancer immunotherapy: advances, challenges, and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1609840
- 350 views
Type at least 3 characters
1,459 articles
Original Research
Published on 15 Aug 2025
PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1534545
- 259 views
Case Report
Published on 15 Aug 2025
Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1576892
- 261 views
Original Research
Accepted on 13 Aug 2025
The Application of Peripheral Blood Immune Profiling in Personalized Treatment of Locally Advanced and Advanced Lung Cancer: A Nomogram Approach
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1642829
Correction
Published on 13 Aug 2025
Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1645247
- 307 views
Original Research
Published on 13 Aug 2025
Extracellular matrix-related genes-based prognostic signature for cervical cancer: association of LAMA4 expression with prognosis and response to immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1562115
- 335 views
Original Research
Published on 13 Aug 2025
Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1575376
- 226 views
Original Research
Published on 13 Aug 2025
Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1606599
- 327 views
Original Research
Published on 12 Aug 2025
Comprehensive single-cell sequencing reveals the tumor microenvironment and tumor-specific characteristics in trachea squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1575647
- 372 views
Mini Review
Published on 08 Aug 2025
Impact of sympathetic nervous system on immune evasion in high-grade serous ovarian cancer: a review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1644895
- 518 views
Original Research
Published on 08 Aug 2025
CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1625120
- 370 views
Study Protocol
Published on 08 Aug 2025
Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective, single arm, phase II study (STARS - RC06)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1594927
- 369 views
Original Research
Published on 08 Aug 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1622008
- 326 views
Original Research
Accepted on 07 Aug 2025
Claudin18.2 Defines a Prognostically Distinct Subgroup of Intrahepatic Cholangiocarcinoma via CD8 + T-Cell Exclusion
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1636367
- 139 views
Study Protocol
Published on 06 Aug 2025
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1633324
- 585 views
Case Report
Accepted on 04 Aug 2025
Curative effect and mechanism of sovantinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1527719
- 172 views